Numerous scientific symposia, lectures, and poster presentations showcased current studies on innovative approaches to obesity treatment, new standards of care, and the latest data on GLP-1-based medications.
“This year’s agenda showcases our dedication to pushing the boundaries of research, encouraging innovation, and ultimately enhancing the lives of people living with diabetes and obesity,” said Rita Rastogi Kalyani, ADA President of Medicine & Science.
We are proud that our researchers (from left to right: Prof. Dr. Andreas Birkenfeld, Arvid Sandforth, Leontine Sandforth, Prof. Dr. Reiner Jumpertz-von Schwartzenberg) contributed to this important international conference with their latest research presented in talks and scientific posters.
About the ADA: The ADA is a major voluntary health organization dedicated to the prevention and cure of diabetes. For more information, visit diabetes.org